In oral squamous cell carcinoma (OSCC) Tca8113 and breast cancer cell lines, rapamycin down-regulated expression of S-phase kinase associated protein-2 (SKP2) and increased FOXO3a protein stability. The gene discussed is SKP2; the disease is breast cancer.